Literature DB >> 28284328

Memory B cells in Guillain-Barré syndrome.

Qian Wang1, Chunye Xing1, Yanlei Hao1, Qiguang Shi1, Ziyou Qi1, Zhanyun Lv1, Yan Song1, Peng Xu1, Xungang Feng1, Lili Zhang1, Yong Zhang2, Yuzhong Wang3, Nobuhiro Yuki4.   

Abstract

IgG autoantibodies against gangliosides show the highest titers at the disease onset of axonal Guillain-Barré syndrome (GBS), in which there are no IgM anti-ganglioside antibodies. We hypothesized that memory B cells take part in the development of producing IgG autoantibodies. In this study, we analyzed the memory B cells in patients with GBS using flow cytometry. There was significantly higher percentage of memory B cells in patients with GBS than the healthy controls. The Spearman correlation analysis demonstrated that increased percentage of memory B cells was positively correlated with the clinical severity of the patients with GBS. Our study provides the evidences that memory B cells may be involved in mechanism of GBS.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Guillain-Barré syndrome; memory B cell

Mesh:

Substances:

Year:  2017        PMID: 28284328     DOI: 10.1016/j.jneuroim.2017.01.004

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  3 in total

Review 1.  Guillain-Barré syndrome: expanding the concept of molecular mimicry.

Authors:  Jon D Laman; Ruth Huizinga; Geert-Jan Boons; Bart C Jacobs
Journal:  Trends Immunol       Date:  2022-03-04       Impact factor: 19.709

Review 2.  Guillain-Barré syndrome, transverse myelitis and infectious diseases.

Authors:  Yhojan Rodríguez; Manuel Rojas; Yovana Pacheco; Yeny Acosta-Ampudia; Carolina Ramírez-Santana; Diana M Monsalve; M Eric Gershwin; Juan-Manuel Anaya
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

3.  The effects of vasoactive intestinal peptide in the rat model of experimental autoimmune neuritis and the implications for treatment of acute inflammatory demyelinating polyradiculoneuropathy or Guillain-Barré syndrome.

Authors:  Hong Jiao; Huan Ren
Journal:  Drug Des Devel Ther       Date:  2018-11-06       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.